{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:00:57Z","timestamp":1793433657214,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014597","name":"LAM Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaip.2026.02.026","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:22:42Z","timestamp":1772526162000},"page":"1529-1539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["What We Have Here Is a Failure to Communicate: Interleukin-12 \/ Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Alicia \u039c.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra F.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Carlo","family":"Anglero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tsoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Passarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.02.026_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00331-22","article-title":"A brief update on mycobacterial taxonomy, 2020 to 2022","volume":"61","author":"Armstrong","year":"2023","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaip.2026.02.026_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fmicb.2018.00067","article-title":"Phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and four novel genera","volume":"9","author":"Gupta","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaip.2026.02.026_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.20506\/rst.20.1.1265","article-title":"The mycobacteria: an introduction to nomenclature and pathogenesis","volume":"20","author":"Rastogi","year":"2001","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.jaip.2026.02.026_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1055\/s-0041-1730997","article-title":"Nontuberculous mycobacteria","volume":"42","author":"Tan","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an Official ATS\/ERS\/ESCMID\/IDSA Clinical Practice Guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0952-7915(98)80114-3","article-title":"Mendelian susceptibility to mycobacterial infection in man","volume":"10","author":"Altare","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00445481","article-title":"Generalized familial semibenign BCG infection, salmonella osteomyelitis and intestinal pseudotuberculosis--due to a familial defect of the macrophage system? (author\u2019s transl)","volume":"121","author":"Heyne","year":"1976","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaip.2026.02.026_bib9","first-page":"1138","article-title":"Our experiences in three years of BCG vaccination at the center of the O.P.H.S. at Constantine; study of observed cases (25 cases of complications from BCG vaccination)","volume":"55","author":"Mimouni","year":"1951","journal-title":"Alger Medicale"},{"key":"10.1016\/j.jaip.2026.02.026_bib10","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","article-title":"A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection","volume":"335","author":"Newport","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib12","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1056\/NEJM199405123301904","article-title":"Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report","volume":"330","author":"Holland","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib13","first-page":"1","article-title":"Report of an IUIS Scientific Committee. International Union of Immunological Societies","volume":"118","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2008.10.037","article-title":"The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases","volume":"122","author":"Al-Muhsen","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4414\/smw.2001.09763","article-title":"Mendelian susceptibility to mycobacterial infection in man","volume":"131","author":"Casanova","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jaip.2026.02.026_bib17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/1744666X.2021.1956314","article-title":"An updated review on Mendelian susceptibility to mycobacterial diseases\u2014a silver jubilee celebration of its first genetic diagnosis","volume":"17","author":"Das","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib18","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaip.2020.01.038","article-title":"Primary immunodeficiency diseases and Bacillus Calmette-Guerin (BCG)-vaccine-derived complications: a systematic review","volume":"8","author":"Fekrvand","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.026_bib19","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/j.jinf.2013.09.024","article-title":"Nontuberculous mycobacterial infections in children with inborn errors of the immune system","volume":"68","author":"Haverkamp","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jaip.2026.02.026_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.cmi.2022.03.004","article-title":"Mendelian susceptibility to mycobacterial diseases: state of the art","volume":"28","author":"Noma","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaip.2026.02.026_bib21","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.ijid.2011.01.004","article-title":"Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases","volume":"15","author":"Qu","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/imcb.12210","article-title":"Mendelian susceptibility to mycobacterial disease: 2014-2018 update","volume":"97","author":"Rosain","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaip.2026.02.026_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.926781","article-title":"An updated review on MSMD research globally and a literature review on the molecular findings, clinical manifestations, and treatment approaches in China","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib25","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jaci.2024.01.021","article-title":"Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): a systematic review","volume":"153","author":"Khavandegar","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib26","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Aziz Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaip.2026.02.026_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/cells9020483","article-title":"Patient iPSC-derived macrophages to study inborn errors of the IFN-gamma responsive pathway","volume":"9","author":"Haake","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2026.02.026_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaip.2026.02.026_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00251-013-0739-0","article-title":"A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients","volume":"66","author":"Ben-Mustapha","year":"2014","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jaip.2026.02.026_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.meegid.2009.02.010","article-title":"A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian susceptibility to mycobacterial diseases in European descendants","volume":"9","author":"Yancoski","year":"2009","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.jaip.2026.02.026_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: the human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12916-016-0606-6","article-title":"\u201cWhy me, why now?\u201d Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection","volume":"14","author":"Lake","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0902-97","article-title":"Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae","volume":"32","author":"Ottenhoff","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2026.02.026_bib34","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1086\/425021","article-title":"Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans","volume":"190","author":"MacLennan","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6759","article-title":"Human IFN-gamma immunity to mycobacteria is governed by both IL-12 and IL-23","volume":"3","author":"Martinez-Barricarte","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq5204","article-title":"Human IL-23 is essential for IFN-gamma-dependent immunity to mycobacteria","volume":"8","author":"Philippot","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1203\/00006450-200107000-00005","article-title":"Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood","volume":"50","author":"Remus","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaip.2026.02.026_bib38","article-title":"Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings","volume":"4","author":"Cornelissen","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2026.02.026_bib39","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jiph.2023.06.005","article-title":"Novel mutations in genes of the IL-12\/IFN-gamma axis cause susceptibility to tuberculosis","volume":"16","author":"Ahmad","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jaip.2026.02.026_bib40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","article-title":"Mendelian susceptibility to mycobacterial disease: recent discoveries","volume":"139","author":"Bustamante","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaip.2026.02.026_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.aller.2015.04.003","article-title":"Tuberculosis in an autosomal recessive case of chronic granulomatous disease due to mutation of the NCF1 gene","volume":"44","author":"Khan","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2026.02.026_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102804118","article-title":"Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease","volume":"118","author":"Le Voyer","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2026.02.026_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaip.2026.02.026_bib44","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.4049\/jimmunol.1700515","article-title":"Nitric oxide modulates macrophage responses to Mycobacterium tuberculosis infection through activation of HIF-1alpha and repression of NF-kappaB","volume":"199","author":"Braverman","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2026.02.026_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019105","article-title":"Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis","volume":"6","author":"Herbst","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2026.02.026_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1084\/jem.20182031","article-title":"Interferon-induced guanylate-binding proteins: guardians of host defense in health and disease","volume":"216","author":"Tretina","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22632","article-title":"Adult-onset Mendelian susceptibility to mycobacterial diseases: a case report and systematic literature review","volume":"9","author":"Yang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jaip.2026.02.026_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631298","article-title":"Clinical and molecular findings in Mendelian susceptibility to mycobacterial diseases: experience from India","volume":"12","author":"Taur","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib51","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1093\/cid\/ciaf637","article-title":"IL12RB1 deficiency appearing in North America: expanding the clinical phenotypes","volume":"82","author":"Wang","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib52","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib53","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/10408363.2018.1444580","article-title":"Laboratory evaluation of the IFN-gamma circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease","volume":"55","author":"Esteve-Sole","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jaip.2026.02.026_bib54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2016.05.042","article-title":"Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders","volume":"139","author":"Stray-Pedersen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1279112","article-title":"Current genetic diagnostics in inborn errors of immunity","volume":"12","author":"von Hardenberg","year":"2024","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2026.02.026_bib56","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/ACI.0000000000000398","article-title":"Whole exome sequencing in inborn errors of immunity: use the power but mind the limits","volume":"17","author":"Bucciol","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1638544","article-title":"Contribution of next generation sequencing to the diagnosis of inborn errors of immunity in a pediatric cohort","volume":"16","author":"Godinez-Zamora","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib58","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.humimm.2021.02.011","article-title":"Next-generation sequencing for inborn errors of immunity","volume":"82","author":"Lee","year":"2021","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxaf007","article-title":"Application of whole-exome sequencing to predict inborn errors of immunity in pediatric severe infections and sepsis","volume":"219","author":"Moundir","year":"2025","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109758","article-title":"Next generation sequencing (NGS)-based approach to diagnosing Algerian patients with suspected inborn errors of immunity (IEIs)","volume":"256","author":"Peng","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/humu.10150","article-title":"Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO\/IKKgamma dene deletion","volume":"21","author":"Bardaro","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaip.2026.02.026_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaci.2021.11.016","article-title":"Anticytokine autoantibodies: autoimmunity trespassing on antimicrobial immunity","volume":"149","author":"Cheng","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib64","article-title":"Anti-interferon-gamma autoantibodies syndrome and opportunistic infections: systematic literature review","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10875-025-01885-z","article-title":"Deepening understanding of the clinical features and diagnostic approaches to anti-interferon-gamma autoantibody associated adult-onset immunodeficiency in the last 20 years: a case report and literature review","volume":"45","author":"Zhao","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae142","article-title":"The use of dual beta-lactams to restore susceptibility of Mycobacterium avium complex","volume":"6","author":"Al-Jabri","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jaip.2026.02.026_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00319-24","article-title":"Dual beta-lactam for treatment of pulmonary Mycobacterium abscessus in a child","volume":"68","author":"Becken","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2026.02.026_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1394220","article-title":"Treatment for non-tuberculous mycobacteria: challenges and prospects","volume":"15","author":"Conyers","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaip.2026.02.026_bib69","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib70","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.eimc.2017.10.008","article-title":"Treatment of infections caused by nontuberculous mycobacteria","volume":"36","author":"Esteban","year":"2018","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"10.1016\/j.jaip.2026.02.026_bib71","article-title":"Overview of Mendelian susceptibility to mycobacterial diseases (MSMD)","volume":"17","author":"Raghuraman","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jaip.2026.02.026_bib72","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/bjh.70095","article-title":"Interferon-gamma and C-X-C motif chemokine ligand 9, which is better for haemophagocytic lymphohistiocytosis diagnosis and monitoring?","volume":"207","author":"Luo","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2026.02.026_bib73","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.4049\/jimmunol.172.12.7417","article-title":"Chemokine monokine induced by IFN-gamma\/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production","volume":"172","author":"Whiting","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib74","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00834-19","article-title":"Antimycobacterial susceptibility testing of nontuberculous mycobacteria","volume":"57","author":"Brown-Elliott","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaip.2026.02.026_bib76","article-title":"Medication adherence in patients with nontuberculous mycobacterial disease","volume":"40","author":"Lemson","year":"2025","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib77","doi-asserted-by":"crossref","DOI":"10.12771\/emj.2025.00080","article-title":"Current and emerging treatment strategies for Mycobacterium avium complex pulmonary disease: a narrative review","volume":"48","author":"Chung","year":"2025","journal-title":"Ewha Med J"},{"key":"10.1016\/j.jaip.2026.02.026_bib78","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/14656566.2020.1740205","article-title":"State-of-the-art treatment strategies for nontuberculous mycobacteria infections","volume":"21","author":"Munoz-Egea","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaip.2026.02.026_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab093","article-title":"Tedizolid vs linezolid for the treatment of nontuberculous mycobacteria infections in solid organ transplant recipients","volume":"8","author":"Poon","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib80","first-page":"453","article-title":"Clinical and laboratory features of Mycobacterium abscessus subsp abscessus and subsp bolletii infections in the United States","volume":"52","author":"Wallace","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib81","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlad104","article-title":"Evaluation of omadacycline against intracellular Mycobacterium abscessus in an infection model in human macrophages","volume":"5","author":"Jahanbakhsh","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jaip.2026.02.026_bib82","series-title":"CLSI Standards: Guidelines for Health Care Excellence","author":"Woods","year":"2011"},{"key":"10.1016\/j.jaip.2026.02.026_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TNMI7-0024-2016","article-title":"Nontuberculous mycobacteria\u2014overview","volume":"5","author":"Koh","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jaip.2026.02.026_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2023.06.026","article-title":"The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission","volume":"29","author":"Dedrick","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaip.2026.02.026_bib85","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2026.02.026_bib86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10875-024-01716-7","article-title":"A novel combination of compound heterozygous variants in IFNGR1 causing complete IFNGR1 deficiency","volume":"44","author":"Labere","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib87","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s10875-021-01116-1","article-title":"Outcome of hematopoietic stem cell transplantation in patients with Mendelian susceptibility to mycobacterial diseases","volume":"41","author":"Radwan","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib88","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/blood-2017-10-812859","article-title":"Hematopoietic stem cell gene therapy for IFNgammaR1 deficiency protects mice from mycobacterial infections","volume":"131","author":"Hetzel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.02.026_bib89","article-title":"Infection-associated immune reconstitution inflammatory syndrome in hematopoietic cell transplantation","volume":"27","author":"Chaturvedi","year":"2025","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib90","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.bmt.1705399","article-title":"Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency","volume":"38","author":"Chantrain","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaip.2026.02.026_bib91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jpeds.2004.08.021","article-title":"Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey","volume":"145","author":"Roesler","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaip.2026.02.026_bib92","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10875-020-00826-2","article-title":"Successful matched related bone marrow transplantation in a patient with autosomal dominant interferon gamma receptor 1 deficiency","volume":"40","author":"Zerbe","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib93","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood-2017-03-771600","article-title":"Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG\/NEMO mutations","volume":"130","author":"Miot","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.02.026_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050026","article-title":"IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts","volume":"5","author":"Rottman","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib95","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00043426-200401000-00020","article-title":"Non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from a family donor based on fetomaternal microchimerism in pediatric hematologic malignancies","volume":"26","author":"Ishida","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaip.2026.02.026_bib96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciac453","article-title":"Phage therapy of mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease","volume":"76","author":"Dedrick","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2026.02.026_bib97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccm.2014.10.003","article-title":"Environmental sources of nontuberculous mycobacteria","volume":"36","author":"Falkinham","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jaip.2026.02.026_bib98","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fimmu.2019.00621","article-title":"Mycobacteria-specific T cells may be expanded from healthy donors and are near absent in primary immunodeficiency disorders","volume":"10","author":"Patel","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib99","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jaci.2015.12.1311","article-title":"Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes","volume":"137","author":"Naik","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.026_bib100","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2943113","article-title":"Autologous cytokine-induced killer cell immunotherapy enhances chemotherapy efficacy against multidrug-resistant tuberculosis","volume":"2022","author":"Tang","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaip.2026.02.026_bib101","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.anai.2025.07.029","article-title":"Communicating compassion in the face of grief and loss in allergy-immunology","volume":"135","author":"Shaker","year":"2025","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:52:47Z","timestamp":1786013567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":100,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2213219826001789"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.026","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What We Have Here Is a Failure to Communicate: Interleukin-12 \/ Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}